Skip to main content
Top
Gepubliceerd in:

18-04-2018

Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases

Auteurs: Carlos K. H. Wong, Edmond P. H. Choi, Y. C. Woo, Brian H. H. Lang

Gepubliceerd in: Quality of Life Research | Uitgave 8/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To evaluate the validity and reliability of a newly-translated Thyroid-specific Patient-Reported Outcome short-form (ThyPRO-39) instrument for ethnic-Chinese patients suffering from benign thyroid diseases.

Methods

The translation and cross-cultural adaptation of the English ThyPRO-39 were performed using the double forward translation, reconciliation, single backward translation, and cognitive debriefing, followed by a panel review. Cross-sectional data of 308 patients with benign thyroid diseases were utilized for this psychometric evaluation of ThyPRO-39 instrument. Convergent validity between similar construct in the ThyPRO-39, SF-6D, and SF-12v2 was assessed using Spearman correlations. The internal construct validity was assessed by corrected item-total correlations. Sensitivity of the ThyPRO-39 domain scores was determined by performing known group comparisons by independent t test. The internal consistency reliability was assessed by Cronbach’s alpha coefficient.

Results

Significant floor effects were observed in 9 out of 13 domains of the ThyPRO-39. The hypothesized correlations between similar constructs in the ThyPRO-39 and the SF-12v2 and SF-6D were generally observed, supporting convergent validity. The internal construct validity was supported in most items, except eight items in six scales. Scale score of hyperthyroid symptoms of the ThyPRO-39 was significantly higher in the group with Graves’ disease or hyperthyroid disease than the group without Graves’ disease nor hyperthyroid disease. Scale scores of eye symptoms and impaired daily life were significantly higher in the incidental group than the non-incidental group. For six domains (hyperthyroid symptoms, hypothyroid symptoms, eye symptoms, tiredness, depressivity, and emotional susceptibility), Cronbach’s alpha did not reach the recommended standard of 0.7.

Conclusions

This was the first psychometric study to translate and adapt the ThyPRO-39 instrument for non-Caucasian patients, and report its validity and reliability for use in Chinese patients with benign thyroid diseases. Given the low item-total correlations in eight items and low internal consistency reliability in respective scales of the ThyPRO-39, we suggest that the improvement of those eight items should produce a more valid and reliable ThyPRO-39 instrument.
Literatuur
1.
go back to reference Garmendia Madariaga, A., Santos Palacios, S., Guillén-Grima, F., & Galofré, J. C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 99(3), 923–931.CrossRef Garmendia Madariaga, A., Santos Palacios, S., Guillén-Grima, F., & Galofré, J. C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: A meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 99(3), 923–931.CrossRef
2.
go back to reference Wang, J., Ma, X., Qu, S., Li, Y., Han, L., Sun, X., et al. (2013). High prevalence of subclinical thyroid dysfunction and the relationship between thyrotropin levels and cardiovascular risk factors in residents of the coastal area of China. Experimental & Clinical Cardiology, 18(1), e16. Wang, J., Ma, X., Qu, S., Li, Y., Han, L., Sun, X., et al. (2013). High prevalence of subclinical thyroid dysfunction and the relationship between thyrotropin levels and cardiovascular risk factors in residents of the coastal area of China. Experimental & Clinical Cardiology, 18(1), e16.
3.
go back to reference Morris, L. G., Sikora, A. G., Tosteson, T. D., & Davies, L. (2013). The increasing incidence of thyroid cancer: The influence of access to care. Thyroid, 23(7), 885–891.CrossRefPubMedPubMedCentral Morris, L. G., Sikora, A. G., Tosteson, T. D., & Davies, L. (2013). The increasing incidence of thyroid cancer: The influence of access to care. Thyroid, 23(7), 885–891.CrossRefPubMedPubMedCentral
4.
go back to reference Leese, G., Flynn, R., Jung, R., Macdonald, T., Murphy, M., & Morris, A. (2008). Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: The Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology (Oxford), 68(2), 311–316. Leese, G., Flynn, R., Jung, R., Macdonald, T., Murphy, M., & Morris, A. (2008). Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: The Thyroid Epidemiology Audit and Research Study (TEARS). Clinical Endocrinology (Oxford), 68(2), 311–316.
5.
go back to reference Lang, B. H., Wong, C. K., & Chan, C. T. (2015). Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective. European Journal of Surgical Oncology (EJSO), 41(6), 758–765.CrossRef Lang, B. H., Wong, C. K., & Chan, C. T. (2015). Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective. European Journal of Surgical Oncology (EJSO), 41(6), 758–765.CrossRef
6.
go back to reference Watt, T., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., Bjorner, J. B., et al. (2006). Quality of life in patients with benign thyroid disorders. A review. European Journal of Endocrinology, 154(4), 501–510.CrossRefPubMed Watt, T., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., Bjorner, J. B., et al. (2006). Quality of life in patients with benign thyroid disorders. A review. European Journal of Endocrinology, 154(4), 501–510.CrossRefPubMed
7.
go back to reference Links, T., Van Tol, K., Jager, P., Plukker, J. T. M., Piers, D., Boezen, H., et al. (2005). Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis. Endocrine-Related Cancer, 12(2), 273–280.CrossRefPubMed Links, T., Van Tol, K., Jager, P., Plukker, J. T. M., Piers, D., Boezen, H., et al. (2005). Life expectancy in differentiated thyroid cancer: A novel approach to survival analysis. Endocrine-Related Cancer, 12(2), 273–280.CrossRefPubMed
8.
go back to reference Schlumberger, M. J. (1998). Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338(5), 297–306.CrossRefPubMed Schlumberger, M. J. (1998). Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338(5), 297–306.CrossRefPubMed
9.
10.
go back to reference Büttner, M., Musholt, T. J., & Singer, S. (2017). Quality of life in patients with hypoparathyroidism receiving standard treatment: A systematic review. Endocrine, 58(1), 14–20.CrossRefPubMed Büttner, M., Musholt, T. J., & Singer, S. (2017). Quality of life in patients with hypoparathyroidism receiving standard treatment: A systematic review. Endocrine, 58(1), 14–20.CrossRefPubMed
11.
go back to reference Husson, O., Haak, H. R., Oranje, W. A., Mols, F., Reemst, P. H., & van de Poll-Franse, L. V. (2011). Health-related quality of life among thyroid cancer survivors: A systematic review. Clinical Endocrinology (Oxford), 75(4), 544–554.CrossRef Husson, O., Haak, H. R., Oranje, W. A., Mols, F., Reemst, P. H., & van de Poll-Franse, L. V. (2011). Health-related quality of life among thyroid cancer survivors: A systematic review. Clinical Endocrinology (Oxford), 75(4), 544–554.CrossRef
12.
go back to reference Elberling, T., Rasmussen, A., Feldt-Rasmussen, U., Hording, M., Perrild, H., & Waldemar, G. (2004). Impaired health-related quality of life in Graves’ disease. A prospective study. European Journal of Endocrinology, 151(5), 549–555.CrossRefPubMed Elberling, T., Rasmussen, A., Feldt-Rasmussen, U., Hording, M., Perrild, H., & Waldemar, G. (2004). Impaired health-related quality of life in Graves’ disease. A prospective study. European Journal of Endocrinology, 151(5), 549–555.CrossRefPubMed
13.
go back to reference Wong, C. K., Lang, B. H., & Lam, C. L. (2016). A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. Journal of Clinical Epidemiology, 78, 63–72.CrossRefPubMed Wong, C. K., Lang, B. H., & Lam, C. L. (2016). A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. Journal of Clinical Epidemiology, 78, 63–72.CrossRefPubMed
14.
go back to reference Watt, T., Rasmussen, ÅK., Groenvold, M., Bjorner, J. B., Watt, S. H., Bonnema, S. J., et al. (2008). Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Quality of Life Research, 17(7), 1009.CrossRefPubMed Watt, T., Rasmussen, ÅK., Groenvold, M., Bjorner, J. B., Watt, S. H., Bonnema, S. J., et al. (2008). Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Quality of Life Research, 17(7), 1009.CrossRefPubMed
15.
go back to reference Watt, T., Bjorner, J. B., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., et al. (2009). Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): An initial examination. Quality of Life Research, 18(4), 483–496.CrossRefPubMed Watt, T., Bjorner, J. B., Groenvold, M., Rasmussen, ÅK., Bonnema, S. J., Hegedüs, L., et al. (2009). Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): An initial examination. Quality of Life Research, 18(4), 483–496.CrossRefPubMed
16.
go back to reference Watt, T., Hegedüs, L., Groenvold, M., Bjorner, J. B., Rasmussen, ÅK., Bonnema, S. J., et al. (2010). Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. European Journal of Endocrinology, 162(1), 161–167.CrossRefPubMed Watt, T., Hegedüs, L., Groenvold, M., Bjorner, J. B., Rasmussen, ÅK., Bonnema, S. J., et al. (2010). Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. European Journal of Endocrinology, 162(1), 161–167.CrossRefPubMed
17.
go back to reference Watt, T., Barbesino, G., Bjorner, J. B., Bonnema, S. J., Bukvic, B., Drummond, R., et al. (2015). Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Quality of Life Research, 24(3), 769–780.CrossRefPubMed Watt, T., Barbesino, G., Bjorner, J. B., Bonnema, S. J., Bukvic, B., Drummond, R., et al. (2015). Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Quality of Life Research, 24(3), 769–780.CrossRefPubMed
18.
go back to reference Watt, T., Bjorner, J. B., Groenvold, M., Cramon, P., Winther, K. H., Hegedüs, L., et al. (2015). Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid, 25(10), 1069–1079.CrossRefPubMed Watt, T., Bjorner, J. B., Groenvold, M., Cramon, P., Winther, K. H., Hegedüs, L., et al. (2015). Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid, 25(10), 1069–1079.CrossRefPubMed
19.
go back to reference Sawicka-Gutaj, N., Watt, T., Sowinski, J., Gutaj, P., Waligorska-Stachura, J., & Ruchala, M. (2015). ThyPROpl-The Polish version of the thyroid-specific quality of life questionnaire ThyPRO. Endokrynologia Polska, 66(4), 367–380.CrossRefPubMed Sawicka-Gutaj, N., Watt, T., Sowinski, J., Gutaj, P., Waligorska-Stachura, J., & Ruchala, M. (2015). ThyPROpl-The Polish version of the thyroid-specific quality of life questionnaire ThyPRO. Endokrynologia Polska, 66(4), 367–380.CrossRefPubMed
20.
go back to reference Gerenova, J., Watt, T., & Dimanova, B. D. (2017). ThyPRO-39bg: Translation and validation in Bulgarian of thyroid-specific quality of life questionnaire ThyPRO-39. Endocrinologia, 22(1), 12–20. Gerenova, J., Watt, T., & Dimanova, B. D. (2017). ThyPRO-39bg: Translation and validation in Bulgarian of thyroid-specific quality of life questionnaire ThyPRO-39. Endocrinologia, 22(1), 12–20.
21.
go back to reference Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8(2), 94–104.CrossRefPubMed Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8(2), 94–104.CrossRefPubMed
22.
go back to reference Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., et al. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1–133.CrossRefPubMedPubMedCentral Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., et al. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26(1), 1–133.CrossRefPubMedPubMedCentral
23.
go back to reference Lam, E. T., Lam, C. L., Fong, D. Y., & Huang, W. W. (2013). Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese? Journal of Evaluation in Clinical Practice, 19(1), 200–208.CrossRefPubMed Lam, E. T., Lam, C. L., Fong, D. Y., & Huang, W. W. (2013). Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese? Journal of Evaluation in Clinical Practice, 19(1), 200–208.CrossRefPubMed
24.
go back to reference Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed
25.
go back to reference Lam, C. L., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.CrossRefPubMed Lam, C. L., Brazier, J., & McGhee, S. M. (2008). Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value in Health, 11(2), 295–303.CrossRefPubMed
26.
go back to reference McGhee, S. M., Brazier, J., Lam, C., Wong, L., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed McGhee, S. M., Brazier, J., Lam, C., Wong, L., Chau, J., Cheung, A., et al. (2011). Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(Suppl 6), 17–21.PubMed
27.
go back to reference Wong, C. K. H., Lang, B. H. H., Yu, H. M. S., & Lam, C. L. K. (2017). EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: Acceptability and psychometric evaluation. The Patient, 10(4), 447–454.CrossRefPubMed Wong, C. K. H., Lang, B. H. H., Yu, H. M. S., & Lam, C. L. K. (2017). EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: Acceptability and psychometric evaluation. The Patient, 10(4), 447–454.CrossRefPubMed
28.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42.CrossRefPubMed
29.
go back to reference Ware, J. E., & Gandek, B. (1998). Methods for testing data quality, scaling assumptions, and reliability: The IQOLA project approach. Journal of Clinical Epidemiology, 51(11), 945–952.CrossRefPubMed Ware, J. E., & Gandek, B. (1998). Methods for testing data quality, scaling assumptions, and reliability: The IQOLA project approach. Journal of Clinical Epidemiology, 51(11), 945–952.CrossRefPubMed
30.
go back to reference Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill. Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.
31.
go back to reference Bowling, A. (2005). Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health-UK, 27(3), 281–291.CrossRef Bowling, A. (2005). Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health-UK, 27(3), 281–291.CrossRef
32.
go back to reference Lewis-Beck, M., Bryman, A. E., & Liao, T. F. (2003). The SAGE encyclopedia of social science research methods. Thousand Oaks: SAGE. Lewis-Beck, M., Bryman, A. E., & Liao, T. F. (2003). The SAGE encyclopedia of social science research methods. Thousand Oaks: SAGE.
33.
go back to reference Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27, S217–S32.CrossRefPubMed Patrick, D. L., & Deyo, R. A. (1989). Generic and disease-specific measures in assessing health status and quality of life. Medical Care, 27, S217–S32.CrossRefPubMed
34.
go back to reference Bianchi, G. P., Zaccheroni, V., Solaroli, E., Vescini, F., Cerutti, R., Zoli, M., et al. (2004). Health-related quality of life in patients with thyroid disorders. Quality of Life Research, 13(1), 45–54.CrossRefPubMed Bianchi, G. P., Zaccheroni, V., Solaroli, E., Vescini, F., Cerutti, R., Zoli, M., et al. (2004). Health-related quality of life in patients with thyroid disorders. Quality of Life Research, 13(1), 45–54.CrossRefPubMed
Metagegevens
Titel
Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases
Auteurs
Carlos K. H. Wong
Edmond P. H. Choi
Y. C. Woo
Brian H. H. Lang
Publicatiedatum
18-04-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1857-9

Andere artikelen Uitgave 8/2018

Quality of Life Research 8/2018 Naar de uitgave